logo
episode-header-image
Apr 2023
22m 14s

🏋️ “A slimdown in a syringe” — Weight W...

Nick & Jack Studios
About this episode
The latest fad diet isn’t a diet, it’s a shot — Ozempic is being called a miracle weight loss drug, and it’s disrupting Weight Watchers. LVMH is proud of their pricey perfume, and they are selling more than ever thanks to their Rihanna-aided storytelling. And H&R Block vs. TurboTax is the tax prep rivalry we’re all thinking about, but they share a common goal: Keep Taxes Hard. Take our weekly TBOY pop-biz pop-quiz at go.tboypod.com$WW $NVO $LVMUY $INTU $HRBWant merch, a shoutout, or got TheBestFactYet? Go to: www.tboypod.comFollow The Best One Yet on Instagram, Twitter, and Tiktok: @tboypodAnd now watch us on YoutubeLearn more about your ad choices. Visit podcastchoices.com/adchoices

Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
🛒 “UberCartDashBnB” — Airbnb’s new bets. Boxed Wine’s boom. Robinhood’s seed farmer. +LinkedIn Snitches
Airbnb stock had its best day ever Friday… because of car rentals, luggage storage, & Gigagedon.Robinhood is IPO-ing a VC fund with Y Combinator companies… it’s super seedy (in a good way).Boxed wine sales rose 144% in the last 12 months… Luxury labels are slapping-the-bag.Plus, ... Show More
20m 55s
Aug 7
🌶️ “Sloppy Nachos” — Chili’s AI rejection. Tubi’s Adam Sandler strategy. Zoox’s Amazon ATH. +Sam’s Influencer Camp
Amazon is #1 in the Mag7 in 2026... And its Zoox pedal-less robocab is about to get its 1st fare.Just after Pringles embraced AI, Chili’s is spitting it out… Here’s what Chili’s bought instead.The biggest TV biz is hidden under Hollywood’s nose: Tubi… Fox Corp owns the Adam Sandl ... Show More
20m 53s
Aug 6
👉 “Poke” — MySpace vs. DisTok. Travis Kalanick’s future-port. Pringles’ perfect AI potato. +Spreadsheet Dating
MySpace makes a comeback & Disney partners with TikTok… It’s social media’s 2 destinies.Your next Pringle may be perfect… because AI perfected the potato with “Digital Twins.”Ousted Uber founder Travis Kalanick is back with a new startup… Atoms is building vertiports with Joby.Pl ... Show More
22m 23s
Recommended Episodes
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ... Show More
39m 12s
Jul 2023
How Many Points Is a Shot of Wegovy?
WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen HuetSee omnystudio.com/listener for privacy information. 
27m 2s
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s
Jul 2023
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ... Show More
28m 5s
Jul 2022
FT Weekend: A new weight-loss drug works. Is that good?
<p>This week, we hear about a new 'miracle' weight-loss drug called Wegovy. It has unprecedented clinical results and endorsements from celebrities such as Queen Latifah. But critics say it deals with the symptom but not the cause. Then, we’re joined by Lauren Indvik, the FT's fa ... Show More
29m 14s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s